Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

597.30 USD UNCHANGED
Streaming Delayed Price Updated: 4:02 AM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bio-Rad Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Bio-Rad to Participate in Citi’s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last,... 
From Business Wire News Releases
Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with Chicago Public Schools (CPS) to... 
From Business Wire News Releases
Bio-Rad Reports Fourth-Quarter and Full-Year 2020 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the fourth quarter ended December 31,... 
From Business Wire News Releases
Bio-Rad to Report Fourth-Quarter and Full-Year 2020 Financial Results Thursday, February 11, 2021
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the fourth quarter and full year 2020 on... 
From Business Wire News Releases
Bio-Rad to Participate in Fireside Chat at the 39th Annual J.P. Morgan Healthcare Conference on January 11
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last,... 
From Business Wire News Releases
Bio-Rad Provides Outlook Through 2023
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today its outlook through 2023, which shows the company’s... 
From Business Wire News Releases
Thinking about trading options or stock in Farfetch, Carnival Corp, General Electric, Tilray, or Bio-Rad Laboratories?
InvestorsObserver issues critical PriceWatch Alerts for FTCH, CCL, GE, TLRY, and BIO. 
From PR Newswire
Bio-Rad Reports Third-Quarter 2020 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30,... 
From Business Wire News Releases
Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the third quarter 2020 on Thursday, October... 
From Business Wire News Releases
Immunofluorescence Assay Market Analysis with Research Report 2020 to 2026
Harrisburg, NC -- (SBWIRE) -- 10/15/2020 -- The Immunofluorescence Assay Market report helps identify the biggest opportunities in Immunofluorescence Assay industry space and offers accurate latent... 
From SBWire - Latest Press Releases
High Content Screening Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
Tags Technology
From AB Newswire
BioGX Announces FDA Emergency Use Authorization Submission Of Extraction-Free Direct RT-PCR Test for COVID-19
Tags Pharmaceuticals & Biotech
From Get News
In-Vitro Diagnostics (IVD) Packaging Market Size, Status, Global Outlook 2020 to 2025
Harrisburg, NC -- (SBWIRE) -- 10/02/2020 -- The In-vitro Diagnostics (IVD) Packaging Market Research Report 2020 to 2025 presents an in-depth assessment of the Station In-vitro Diagnostics (IVD)... 
From SBWire - Latest Press Releases
Biodesix to Provide COVID-19 Testing for Colorado State University Campus
Biodesix, Inc., a leading diagnostic company with a focus in lung disease, today announced plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University (CSU) as students return to... 
From Business Wire News Releases
Undervalued US Stocks With Bullish Signals: $ASX $BIO $MFC
Tags The Market Signal
From The Market Signal
The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the United States Court of Appeals for the Federal Circuit... 
From Business Wire News Releases
Bio-Rad Reports Second-Quarter 2020 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the second quarter ended June 30,... 
From Business Wire News Releases
Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2020 on Thursday, July... 
From Business Wire News Releases
S&P Dow Jones Indices Announces Tyler Technologies, Bio-Rad Laboratories and Teledyne Technologies Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range.... 
From PR Newswire
Biodesix Collaborates With Bio-Rad to Launch a Serology Test to Detect Coronavirus (COVID-19) Antibodies
Biodesix, Inc., a leading diagnostic company in lung disease, today announced that it has collaborated with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based... 
From Business Wire News Releases
Bio-Rad Reports First-Quarter 2020 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31,... 
From Business Wire News Releases
Bio-Rad Receives FDA Emergency Use Authorization for Droplet Digital PCR SARS-CoV-2 Test Kit
Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its SARS-CoV-2 Droplet Digital PCR (ddPCR) test kit has... 
From Business Wire News Releases
Bio-Rad’s SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it was granted U.S. Food and Drug Administration (FDA)... 
From Business Wire News Releases
Bio-Rad to Report First-Quarter 2020 Financial Results Wednesday, May 6, 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2020 on Wednesday, May 6,... 
From Business Wire News Releases
Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the commercial launch of its SARS-CoV-2 Total Ab test, a... 
From Business Wire News Releases
Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has acquired Celsee, Inc., a company that offers... 
From Business Wire News Releases
Biodesix Begins Coronavirus COVID-19 Testing
Biodesix, Inc., a leading diagnostic company in lung disease, today announced that it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit... 
From Business Wire News Releases
Bio-Rad Announces the Launch of a Serology Assay to Detect Coronavirus (COVID-19) Antibodies
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the company is launching a blood-based immunoassay kit... 
From Business Wire News Releases
Biodesix Partners with Bio-Rad to Bring Emergency Use Authorization (EUA) COVID-19 ddPCR™ Test to the U.S.
Biodesix, Inc., a leading diagnostic company in lung disease, today announced a partnership with Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) to bring a COVID-19 Droplet Digital PCR (ddPCR) test... 
From Business Wire News Releases
New Studies Find Bio-Rad’s QX200 Droplet Digital PCR System Can Detect COVID-19 With Greater Sensitivity and Precision Than Other Existing Molecular Tests
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that in two studies published this month, ahead of... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.